Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

2019C522 Product name: Paclitaxel micellair

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
2019C/522
Type:
Certificate
SPC type:
Medical
Basic patent number:
088615265
Status:
Open & Published
Publication number:
2019C522
1rst applicant's nationality:
Procedural language:
Dutch

Marketing authorization

Marketing authorization number:
EU/1/18/1292
Marketing authorization type:
National/EU
Designates country:
No
Marketing authorization date:
22/11/2018
Marketing authorization status:
Accepted
Marketing authorization country:
Belgium (BE)

Dates

Filing date:
06/05/2019
First marketing authorization date:
22/11/2018
Grant date:
Activation date:
BE Publication date:
09/05/2019
Lapsed date:
Expiration date (if granted and all annual fees paid):
Basic SPC Expiration (if granted and all annual fees paid):
22/11/2033
SPC/SPC Extension Expiration (if granted and all annual fees paid):
22/11/2033
Rejection date:
Withdrawal date:

Applicant

1

Name:
Oasmia Pharmaceutical AB
Legal Form:
From:
23/04/2021
Address:
Vallongatan 1, 752 28 Uppsala, Sweden (SE)
To:

2

Name:
Ardenia Investments Ltd.
Legal Form:
From:
23/04/2021
Address:
23 Portland House, Glacis Road, GX11 1AA Gibraltar, United Kingdom (GB)
To:
23/04/2021

Agent

1

Name:
GEVERS PATENTS
Legal Form:
From:
08/02/2024
Address:
De Kleetlaan 7A, 1831, DIEGEM, Belgium (BE)
To:

2

Name:
GEVERS PATENTS
Legal Form:
From:
07/05/2019
Address:
Holidaystraat 5, 1831, DIEGEM, Belgium (BE)
To:
08/02/2024

Publication

Bulletin

1

Bulletin heading:
SPC
Journal edition number:
2019/15
Publication date:
13/06/2019
Description:
Contains data concerning applications for- or granted Supplementary Protection Certificates

2

Bulletin heading:
CO
Journal edition number:
2021/14
Publication date:
18/08/2021
Description:
Contains data concerning registered assignments or changes of the names of applicants and holders

Deed

Change of owner(s)

Change Kind / Decision Type:
Other
Deed number:
RC2021100404B
Registration date:
23/04/2021
License effective date:
License expiration date:
Scope of license:
Deed filer:
GEVERS PATENTS
Bulletin edition number:
Text:
Décision finale d'une procédure d'arbitrage
Country code:
Updated license number:
Terminated license number:

Removed pledgee

Name:
Address:

Changed pledgee

Name:
Address:

Removed usufructuary

Name:
Address:

Added usufructuary

Name:
Address:

Changed usufructuary

Name:
Address:

Annual fee

Annual fee(s) Due Date:
01/01/2029
Annual fee number:
21
Annual fee amount:
650 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
06/05/2019 General Document Other 2 PDF /9/0/9/1/5/0721851909/docs/2019c522_0_generaldocument_20190507_082204765.pdf
06/05/2019 Marketing Authorization 1st Marketing Authorization (EU) 4 PDF /9/0/9/1/5/0721851909/docs/2019c522_1_marketingauthorization_20190507_082207656.pdf
06/05/2019 General Document Other 121 PDF /9/0/9/1/5/0721851909/docs/2019c522_2_generaldocument_20190507_082201219.pdf
06/05/2019 Abstract Product Characteristics Abstract of the characteristics of the product 38 PDF /9/0/9/1/5/0721851909/docs/2019c522_3_abstractproductcharacteristics_20190507_082205593.pdf
06/05/2019 Application Form 3 PDF /9/0/9/1/5/0721851909/docs/2019c522_4_applicationform_20190507_082208176.pdf
09/05/2019 Front Page 1 PDF /9/0/9/1/5/0721851909/docs/2019c522_5_i1frontpage_20190509_093913469.pdf
23/04/2021 Incoming Correspondence (Email) Cover letter 1 PDF /9/0/9/1/5/0721851909/docs/2019c522_6_incomingcorrespondenceelectronic_20210424_085140824.pdf
09/05/2019 Publication I1 1 PDF /9/0/9/1/5/0721851909/docs/2019c522_7_i1document_20190509_093914674.pdf
06/05/2019 General Document Other 10 PDF /9/0/9/1/5/0721851909/docs/2019c522_8_generaldocument_20190507_082206684.pdf
08/02/2024 Request For Change Letter and/or Form requesting a change in the Register 2 PDF /9/0/9/1/5/0721851909/docs/2019c522_9_rfc_20240425_085642791.pdf